Dr. Cohen is President of the Hepatitis B Foundation, leading national and international efforts to eliminate hepatitis B through developing partnerships, capacity and strategies to improve hepatitis B and D screening, vaccination, and linkage to care.
Conflict of Interest: Represents the Hepatitis B Foundation on community advisory boards for Gilead Sciences and GSK; all consulting fees are paid directly to the Hepatitis B Foundation. The Hepatitis B Foundation partners with Clinical Care Options and PeerView on the development, dissemination, and faculty participation for CME courses related to hepatitis B, hepatitis D, and liver cancer, and receives research and program grants from Gilead Sciences, GSK, Vir Biotechnology, Sanofi, Precision BioSciences, GigaGen, Parexel, nChroma, Exact Sciences, Aligos, Mirum, and DiaSorin.